These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 6117290

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 1st communication: effects on the central nervous system.
    Saito T, Fukuda T, Sukamoto T, Yoshidomi M, Morimoto Y, Shimohara K, Ito K.
    Arzneimittelforschung; 1988 Jan; 38(1):66-9. PubMed ID: 2896509
    [Abstract] [Full Text] [Related]

  • 7. Inhibition by azelastine of the immunologically induced histamine release from isolated guinea pig mast cells.
    Fischer B, Schmutzler W.
    Arzneimittelforschung; 1981 Jan; 31(8):1193-5. PubMed ID: 6170297
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacological studies of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101). (5) Action of M73101 on the central nervous system (author's transl)].
    Sato M.
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):695-706. PubMed ID: 575516
    [Abstract] [Full Text] [Related]

  • 9. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on central nervous and sensory systems and other functions.
    Yamamoto S, Takemori E, Hasegawa Y, Nakao K, Inukai T, Nomura M, Morino K, Tsuchiyama M, Hasegawa K, Ikeda H.
    Arzneimittelforschung; 1991 Jun; 41(6):602-7. PubMed ID: 1930347
    [Abstract] [Full Text] [Related]

  • 10. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I, Kihara T, Nakamura S, Hattori Y, Hatta M, Kitakaze Y, Takahama K, Hashimoto Y, Miyata T, Ishihara T.
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [Abstract] [Full Text] [Related]

  • 11. [Effects of suloctidil on the central and peripheral nervous systems].
    Nishi H, Watanabe T, Mori M.
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248
    [Abstract] [Full Text] [Related]

  • 12. Effects of antihistaminic drugs in tests for antidepressant action.
    Rogóz Z, Skuza G, Sowińska H.
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):321-35. PubMed ID: 6119682
    [Abstract] [Full Text] [Related]

  • 13. General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.
    Shintani S, Toba Y, Suzuki S, Ninomiya S, Umezato M, Hiyama T.
    Arzneimittelforschung; 1985 Oct; 35(7A):1157-62. PubMed ID: 4074429
    [Abstract] [Full Text] [Related]

  • 14. [Effects of ritodrine hydrochloride on motor nervous system and central nervous system].
    Ikeda S, Tsukamoto T.
    Nihon Yakurigaku Zasshi; 1984 Sep; 84(3):311-26. PubMed ID: 6500405
    [Abstract] [Full Text] [Related]

  • 15. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.
    Murata T, Sakaya S, Hoshino T, Umetsu T, Hirano T, Nishio S.
    Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems.
    Hirohashi M, Takasuna K, Kasai Y, Usui C, Kojima H.
    Arzneimittelforschung; 1991 Jan; 41(1):19-24. PubMed ID: 1675569
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ, Kretzschmar R, Kreiskott H, Weifenbach H.
    Arzneimittelforschung; 1981 Jan; 31(9a):1580-8. PubMed ID: 7197973
    [Abstract] [Full Text] [Related]

  • 18. [Pharmacological study of mequitazine (LM-209) (III). Action on the central nervous system (author's transl)].
    Fujimura H, Tsurumi K, Yanagihara M, Hiramatsu Y, Tamura Y, Shimizu Y, Hojo M, Yoshida Y, Serizawa I.
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):249-60. PubMed ID: 6120125
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.